Skip to main content

Table 1 Clinical and biochemical characteristics of each group patientsa

From: Association of TM6SF2 rs58542926 gene polymorphism with the risk of non-alcoholic fatty liver disease and colorectal adenoma in Chinese Han population

Characteristic

NAFLD

(n = 201)

NAFLD&CRA

(n = 188)

CRA

(n = 211)

Control

(n = 239)

Age (yr)

54.80 ± 0.56

54.60 ± 0.48

55.10 ± 0.52

54.00 ± 0.78

BMI (kg/m2)

24.56 ± 1.28*

25.45 ± 2.07*

24.12 ± 1.43*

23.05 ± 0.67

CAP (dB/m)

242.56 ± 31.42*@

245.64 ± 29.63*@

230.66 ± 32.33*

201.23 ± 28.67

FPG (mmol/L)

5.01 ± 0.45*

5.24 ± 0.89*

5.09 ± 0.78*

4.78 ± 0.99

TC (mmol/L)

5.49 ± 0.95

5.56 ± 0.87

5.46 ± 0.78

5.43 ± 0.79

TG (mmol/L)

1.96 ± 1.23*

1.98 ± 1.34*

1.89 ± 1.27*

1.48 ± 1.06

LDL-C (mmol/L)

3.32 ± 0.45

3.31 ± 0.79

3.28 ± 0.67

3.20 ± 0.77

HDL-C (mmol/L)

1.33 ± 0.32

1.32 ± 0.37

1.37 ± 0.56

1.38 ± 0.41

AST (U/L)

39.60 ± 8.30*

40.50 ± 9.2*@

34.50 ± 8.50

31.40 ± 7.30

ALT (U/L)

37.20 ± 9.90*@

39.90 ± 10.30*

31.80 ± 11.90

30.90 ± 10.10

UA (μmol/L)

368.76 ± 80.32*

370.58 ± 67.92*

369.61 ± 84.26*

340.56 ± 75.67

  1. Abbreviations: NAFLD non-alcoholic fatty liver disease, CRA colorectal adenoma, BMI body mass index, CAP controlled attenuation parameter, FPG fasting plasma glucose, TC total cholesterol, TG triglyceride, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, AST aspartate aminotransferase, ALT alanine aminotransferase, UA uric acid
  2. *compared with the control group, P < 0.05; @ compared with CRA group, P < 0.05
  3. aData are presented as mean ± SD